These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1793445)

  • 1. Estrogens inhibit copper and cell-mediated modification of low density lipoprotein.
    Mazière C; Auclair M; Ronveaux MF; Salmon S; Santus R; Mazière JC
    Atherosclerosis; 1991 Aug; 89(2-3):175-82. PubMed ID: 1793445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol estrogens are more potent antioxidants than estrogens for the Cu(2+)-catalyzed oxidation of low or high density lipoprotein: antioxidative effects of steroids on lipoproteins.
    Taniguchi S; Yanase T; Kobayashi K; Takayanagi R; Haji M; Umeda F; Nawata H
    Endocr J; 1994 Dec; 41(6):605-11. PubMed ID: 7704084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1 Acyl-2 acetyl-sn-glycero-3 phosphocholine decreases the susceptibility of low-density lipoprotein to oxidative modification by copper ions, monocytes or endothelial cells.
    Maziere C; Djavahery-Mergny M; Auclair M; Maziere JC
    Biochim Biophys Acta; 1994 Jan; 1210(2):233-8. PubMed ID: 8280775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipophilic beta-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteins.
    Mazière C; Auclair M; Mazière JC
    Biochim Biophys Acta; 1992 Jun; 1126(3):314-8. PubMed ID: 1353372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide enhances oxidative modification of low density lipoprotein by copper ions, endothelial and smooth muscle cells.
    Maziere C; Conte MA; Dantin F; Maziere JC
    Atherosclerosis; 1999 Mar; 143(1):75-80. PubMed ID: 10208481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibuprofen protects low density lipoproteins against oxidative modification.
    Zapolska-Downar D; Zapolska-Downar A; Bukowska H; Gałka H; Naruszewicz M
    Life Sci; 1999; 65(22):2289-303. PubMed ID: 10597884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidant potential of specific estrogens on lipid peroxidation.
    Subbiah MT; Kessel B; Agrawal M; Rajan R; Abplanalp W; Rymaszewski Z
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1095-7. PubMed ID: 8408459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole inhibits the oxidative modification of low density lipoprotein.
    Selley ML; Czeti AL; McGuiness JA; Ardlie NG
    Atherosclerosis; 1994 Nov; 111(1):91-7. PubMed ID: 7840817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor enhances low density lipoprotein oxidative modification by monocytes and endothelial cells.
    Maziere C; Auclair M; Maziere JC
    FEBS Lett; 1994 Jan; 338(1):43-6. PubMed ID: 8307154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists prevent monocyte and endothelial cell-induced modification of low density lipoproteins.
    Breugnot C; Mazière C; Auclair M; Mora L; Ronveaux MF; Salmon S; Santus R; Morlière P; Lenaers A; Mazière JC
    Free Radic Res Commun; 1991; 15(2):91-100. PubMed ID: 1756990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of low-density lipoprotein oxidation by 17-beta estradiol.
    Rifici VA; Khachadurian AK
    Metabolism; 1992 Oct; 41(10):1110-4. PubMed ID: 1328822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The inhibition of the oxidation of low density lipoprotein by (+)-catechin, a naturally occurring flavonoid.
    Mangiapane H; Thomson J; Salter A; Brown S; Bell GD; White DA
    Biochem Pharmacol; 1992 Feb; 43(3):445-50. PubMed ID: 1540202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of 5,6,7,8-tetrahydroneopterin on oxidative modification of low-density lipoprotein, and its uptake in the macrophage-like cell line J774.
    Iizuka H; Watanabe Y; Kojima S
    Jpn J Pharmacol; 1996 Dec; 72(4):375-9. PubMed ID: 9015746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of estrogens and phytoestrogenic lignans on macrophage uptake of atherogenic lipoproteins.
    Owen AJ; Abbey M
    Biofactors; 2004; 20(3):119-27. PubMed ID: 15665382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of natural polyphenol compounds on the oxidative modification of low-density lipoproteins].
    Dushkin MI; Zykov AA; Pivovarova EN
    Biull Eksp Biol Med; 1993 Oct; 116(10):393-5. PubMed ID: 8117961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein.
    Jialal I; Vega GL; Grundy SM
    Atherosclerosis; 1990 Jun; 82(3):185-91. PubMed ID: 2375783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol inhibits mesangial cell-mediated oxidation of low-density lipoprotein.
    Neugarten J; Ghossein C; Silbiger S
    J Lab Clin Med; 1995 Oct; 126(4):385-91. PubMed ID: 7561448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen.
    Kalant N; McCormick S; Parniak MA
    Arterioscler Thromb; 1991; 11(5):1322-9. PubMed ID: 1911719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification.
    Hwang J; Wang J; Morazzoni P; Hodis HN; Sevanian A
    Free Radic Biol Med; 2003 May; 34(10):1271-82. PubMed ID: 12726915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.